Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C175643-100 100 µl (1 mg/ml) $434 
FCER2 / CD23 Antibody - IHC of paraffin-embedded Human lymphoma tissue using anti-FCER2 mouse monoclonal antibody.
FCER2 / CD23 Antibody - IHC of paraffin-embedded Carcinoma of Human bladder tissue using anti-FCER2 mouse monoclonal antibody.
FCER2 / CD23 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCER2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCER2.
FCER2 / CD23 Antibody - IHC of paraffin-embedded Human lymphoma tissue using anti-FCER2 mouse monoclonal antibody.
FCER2 / CD23 Antibody - IHC of paraffin-embedded Carcinoma of Human bladder tissue using anti-FCER2 mouse monoclonal antibody.
FCER2 / CD23 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCER2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCER2.
1 of 3
2 of 3
3 of 3

Monoclonal Mouse anti‑Human FCER2 / CD23 Antibody (clone OTI2B6, IHC, WB) LS‑C175643

Monoclonal Mouse anti‑Human FCER2 / CD23 Antibody (clone OTI2B6, IHC, WB) LS‑C175643

Antibody:
FCER2 / CD23 Mouse anti-Human Monoclonal (OTI2B6) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:
Price
Catalog Number
$434
LS-C175643-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
FCER2 / CD23 Mouse anti-Human Monoclonal (OTI2B6) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:

Specifications

Description
CD23 antibody LS-C175643 is an unconjugated mouse monoclonal antibody to human CD23 (FCER2). Validated for IHC and WB.
Target
Human FCER2 / CD23
Synonyms
FCER2 | CD23 antigen | CD23A | CLEC4J | CD23 | Fc-epsilon-RII | IGEBF | Lymphocyte IgE receptor | BLAST-2 | FCE2
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1 Monoclonal
Clone
OTI2B6
Conjugations
Unconjugated
Purification
Protein A/G purified
Modifications
Unmodified. Also available Carrier-free.
Immunogen
Human recombinant protein fragment corresponding to amino acids 48-321 of human FCER2 (NP_001993) produced in SF9 cell.
Specificity
Human CD23
Applications
  • IHC
  • IHC - Paraffin (1:150)
  • Western blot (1:2000)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Presentation
PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About FCER2 / CD23
P06734 NM_002002 NP_001993.2

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/17/2024